Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA).

De Morais, J, Brandt, SD, Jorge, R, Christie, R, Gallegos, A, Sedefov, R and Evans-Brown, M (2020) EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA). European Monitoring Centre for Drugs and Drug Addiction.

[img]
Preview
Text
TR-4F-MDMB-BICA_Advanced-release.pdf - Published Version

Download (751kB) | Preview

Abstract

The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA), a synthetic receptor cannabinoid agonist that has recently emerged on the drug market in Europe, in order to support the risk assessment of the substance which has been requested by the European Commission in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended).

Item Type: Other
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Pharmacy & Biomolecular Sciences
Publisher: European Monitoring Centre for Drugs and Drug Addiction
Date Deposited: 11 Jan 2021 11:36
Last Modified: 11 Jan 2021 11:36
URI: https://researchonline.ljmu.ac.uk/id/eprint/14253

Actions (login required)

View Item View Item